Development of ulcerative colitis under the immunosuppressive effect of cyclosporine
- PMID: 1356531
- PMCID: PMC7087535
- DOI: 10.1007/BF00184805
Development of ulcerative colitis under the immunosuppressive effect of cyclosporine
Abstract
In recent studies, cyclosporine has been used for the treatment of both ulcerative colitis and Crohn's disease. The results of these studies were variable. We report on a patient who was treated for 6 years with cyclosporine after kidney transplantation. He developed chronic distal colitis with all the features of ulcerative colitis. An infectious etiology of the colitis was carefully excluded. High-dose treatment with methylprednisolone was required to induce remission. This report shows that immunosuppressive therapy with cyclosporine did not prevent the development of ulcerative colitis in this patient.
References
-
- Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med. 1989;321:845–850. - PubMed
-
- Coman E, Reinus JF. Cyclosporine use in steroidresistant Crohn's disease — grasping at new straws? Am J Gastroenterol. 1990;85:758–759. - PubMed
-
- Elson CO. Cyclosporine in Crohn's disease — low doses won't do it. Gastroenterology. 1990;98:1383–1384. - PubMed
-
- Gupta S, Keshavarzian A, Hodgson HJ. Cyclosporin in ulcerative colitis. Lancet. 1984;11:1277–1278. - PubMed
-
- James SP. Remission of Crohn's disease after human immunodeficiency virus infection. Gastroenterology. 1988;95:1667–1669. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical